Atlas Trials

A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC

Clinical trial NCT04807114 · UNKNOWN

Trial details

NCT number
NCT04807114
Sponsor
Universitaire Ziekenhuizen KU Leuven
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung Diseases, InterstitialNSCLCImmunotherapy
Start date
2020-02-01
Primary completion
2025-01-31
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.